Developer docs
API playgroundTry for free, no card

Search company profiles

PHAWARE GLOBAL ASSOCIATION

Full company profile

uuid02lm6ar

Namestring
PHAWARE GLOBAL ASSOCIATION
Legal namestring
phaware global association
Websiteurl
phaware.global
Company typeenum
Private
Founded yearint
2015
Descriptiontext

phaware global association is a 501(c)(3) nonprofit founded in 2015 and headquartered in Burbank, California, that develops digital tools, media, and educational programs for the global pulmonary hypertension (PH) community. Its core assets are the Heart Works mobile research application (iOS, Android, Apple Watch, Amazon) — which enables remote six-minute walk testing, wearable-derived actigraphy/heart rate/oxygen saturation capture, and clinical trial matching via Antidote Match — and the 'I'm Aware That I'm Rare' podcast, which has produced over 600 episodes distributed to listeners in 110+ countries. Supplementary content includes the 'Aware I'm Rare' short film, the 'Lips Painted Blue' pediatric animated series, and free CME/CE modules on PAH for healthcare professionals delivered via a partnership with Prime Education.

The platform architecture is built around two technical differentiators: a validated remote 6MWT — under study with Stanford (DynAMITE PAH Study) and the University of Alberta (CRAVE pilot) — that aims to qualify home-based exercise testing for PH clinical trials, and an AI-powered Patient Lived Experience Portal that answers patient questions across 20+ languages using the organization's content library, with audio delivery supported by ElevenLabs through its Impact Program.

The business model is nonprofit and donation- and sponsorship-funded rather than transaction-based. Patient-facing products (app, podcast, films) are free; the only retail product line is branded merchandise sold at a flat $10 unit price (pins, ceramic pendants, PopSockets, earphones) with net proceeds directed to PH research funds. Operating cash flow depends on individual donations (including DAF Direct), grants, and corporate sponsorships from a 2026 roster of six pharmaceutical companies — Merck, Johnson & Johnson, Liquidia Technologies, Gossamer Bio, Pulmovant, and Insmed — plus on-site advertising (e.g., Yutrepia) on phaware.global. Custom primary customers are PH/PAH patients and caregivers, healthcare professionals (pulmonologists, cardiologists, NPs, PAs, pharmacists), and academic clinical researchers; the organization has 1–10 employees.

Short descriptiontext

Phaware global association is a 501(c)(3) nonprofit that builds digital tools, media, and educational programs — including the Heart Works mobile research app and a 600+ episode podcast — to advance pulmonary hypertension awareness, research participation, and clinician education globally across 110+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBurbank, United States
HQ citystring
Burbank
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pulmonary hypertension awareness, rare disease advocacy, patient education resources, mobile health research, medical professional training
Industry3 codes
PRIMARYHLACAOAB
eCOA/ePRO/eDiary & Patient-Facing Data Collection
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYEDAGALAM
Audio Learning Content (Podcasts, Audiobooks, Listening Programs)
Education/Educational Publishing & Learning Content/Educational Media & Multimedia (Video, Audio, Interactive)
NAICS code3 codes
  • Other Similar Organizations (except Business, Professional, Labor, and Political Organizations)813990
  • Motion Picture and Video Industries5121
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Misc Health & Allied Services, Nec8090
  • Miscellaneous Publishing2741
Product category
Rare Disease Advocacy and Patient Education
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Donations and Charitable Contributions
TypeOthers
Description

As a 501(c)(3) nonprofit organization, phaware receives tax-deductible donations from individuals and organizations. The organization promotes donor-advised fund (DAF) giving through DAF Direct.

phaware.global
2Corporate Sponsorship
TypeAffiliate Referral
Description

Annual sponsorship support from pharmaceutical companies including Merck, Johnson & Johnson, Liquidia Technologies, Gossamer Bio, Pulmovant, and Insmed. These sponsorships support webinars, events, and general operations.

phaware.global
3Merchandise Sales
TypeOne Time License
Description

Online store selling branded merchandise (pins, pendants, PopSockets, earphones) at $10 per item. All net proceeds go directly to PH research funds.

phaware.global
4Pharmaceutical Advertising
TypeAdvertising
Description

The platform hosts sponsored content from pharmaceutical companies including Yutrepia (Liquidia Technologies) advertisements on the website.

phaware.global
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Pricing details3 tiers
1Branded merchandise (pins, pendants, PopSockets, earphones) - $10 per item
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Single item pricing at $10.00 each. Includes trading pins (Aware I'm Rare, phaware Logo, All In For PH, etc.), ceramic pendants, PopSockets, earphones, and card protector/challenge coins.

phaware.global
2Heart Works mobile app - Free
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free app available on Apple App Store, Google Play Store. Includes 6MWT, clinical trial matching, podcast access, and educational content.

phaware.global
3CME/CE educational content - Free
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free accredited continuing medical education for healthcare professionals covering PAH diagnosis, treatment, and management topics.

phaware.global
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 3 records shown
1Heart Works
Description

A pulmonary hypertension mobile research and resource app that enables real-time health tracking, at-home six-minute walk tests, remote clinical trial participation, and connects patients with the global PH community.

phaware.global
+2 more records
Core offering1 text field

phaware global association is a 501(c)(3) nonprofit that develops digital tools, media, and educational resources to advance pulmonary hypertension awareness and research. Its core offerings include the Heart Works mobile research app (remote six-minute walk testing, wearable data collection, clinical trial matching, and AI-powered patient education), the 'I'm Aware That I'm Rare' podcast series with 600+ episodes, CME/CE accredited medical education, branded awareness merchandise, and short film/animated content, all distributed globally to patients, caregivers, clinicians, and researchers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 600+ podcast episodes produced and distributed globally
+3 more records
Product overview1 text field

PHAWARE GLOBAL ASSOCIATION operates a unified digital health platform centered on the Heart Works mobile research application, complemented by the I'm Aware That I'm Rare podcast series (600+ episodes), educational films, animated content for children, and CME/CE programs for healthcare professionals. The organization also sells branded merchandise (trading pins, earphones, ceramic pendants, PopSockets) through its store, with all net proceeds directed to pulmonary hypertension research funds. The Heart Works app serves as the primary product, integrating wearable device data collection, clinical trial matching, and AI-powered patient education across 40+ countries.

Product and service3 records
1Heart Works App
CategoryMobile health research application
Description

A free pulmonary hypertension mobile research application for iOS and Android that enables remote patient monitoring, at-home six-minute walk testing with Apple Watch and Android wearables, clinical trial matching via Antidote Match, AI-powered patient education in 20+ languages through the Patient Lived Experience Portal, and access to the global PH community. Available in 40+ countries for PH patients.

2I'm Aware That I'm Rare Podcast
CategoryAudio media / educational content
Description

A weekly podcast series devoted to raising global pulmonary hypertension awareness featuring dynamic stories from PH patients, caregivers, and medical professionals from around the world, with over 600 episodes distributed via standard podcast players and dedicated iPhone, Android, and Amazon apps. Heard in 110+ countries.

3Aware I'm Rare Film
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partner conducting the DynAMITE PAH Study for self-administered 6MWT validation. Dr. Roham Zamanian (Stanford) serves as principal investigator and medical advisor/board member to phaware.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partner for the CRAVE pilot study testing novel therapies for right heart failure in pulmonary hypertension patients. Dr. Jason Weatherald serves as principal investigator.

Strategic tierCoreTypeOthers
Description

European pulmonary hypertension association collaborating with phaware to advance global PH awareness and provide resources for European patients.

Strategic tierCoreTypeOthers
Description

Canadian PH association partnering with phaware for the Vancouver Interviews 2026 event at their PH Community Conference in Vancouver, Canada.

Strategic tierCoreTypeOthers
Description

Pulmonary hypertension network organization collaborating as a core partner in the Heart Works ecosystem to connect patients with PH resources globally.

6Team PHenomenal Hope
Strategic tierMinorTypeOthers
Description

Patient advocacy organization partnering with phaware to support the global PH community through awareness initiatives.

phaware.global
7Pulmonary Hypertension News
Strategic tierMinorTypeOthers
Description

Bionews-owned publication providing PH news content and updates within the Heart Works app platform for patient education.

phaware.global
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Healthcare education company providing free accredited CME/CE activities for healthcare professionals on PAH topics including diagnosis, treatment guidelines, and management strategies.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Pulmonary Hypertension Association (PHA)
TypeBroad incumbent
Description

The leading US-based pulmonary hypertension patient advocacy nonprofit with the largest membership base and longest operating history. PHA is the closest comparable in mission (PH awareness, education, research support) but operates at materially larger scale and offers broader patient services beyond phaware's digital-content focus.

TypeBroad incumbent
Description

US umbrella organization for all rare diseases including PH. Comparable in nonprofit advocacy and patient-education mission, but operates at much larger scale across thousands of conditions rather than specializing in PH.

TypeOthers
Description

Healthcare education company co-developing phaware's accredited CME/CE activities. Comparable as an enabling partner in HCP education rather than a competing advocacy organization, but useful as a benchmark for monetizing PH education content at scale.

TypeRegional player
Description

US patient advocacy nonprofit for scleroderma, a related rare connective-tissue disease that frequently involves pulmonary hypertension. Comparable as a rare-disease advocacy nonprofit with overlapping patient population and similar pharmaceutical-sponsorship model.

TypeDirect peer
Description

European umbrella pulmonary hypertension patient association and active phaware partner. Directly comparable in advocacy mission and PH-awareness content focus, serving the same patient population across Europe rather than competing for the same primary user base.

6Pulmonary Hypertension News (Bionews)
TypeEmerging player
Description

Bionews-owned digital publication providing PH-specific news and patient education; a content partner that runs adjacent to phaware's podcast/app ecosystem. Comparable as a PH-information destination serving the same patient audience via different content format.

7Team PHenomenal Hope
TypeDirect peer
Description

PH patient advocacy nonprofit focused on endurance fundraising and community engagement. Comparable in PH-specific advocacy mission with overlapping digital-community and awareness activities; both compete for similar donor mindshare.

8PPHNet (Pulmonary Hypertension Network)
TypeDirect peer
Description

Pediatric and adult pulmonary hypertension clinical research network and active phaware partner. Comparable in PH-specific mission but more clinically/research-oriented than patient-content-oriented, making it a complementary peer within the same disease niche.

TypeOthers
Description

Clinical trial matching technology provider integrated into phaware's Heart Works app. Comparable as an enabling technology for patient-recruitment workflows, though operating as a vendor/partner rather than a direct advocacy competitor.

TypeDirect peer
Description

Canadian PH patient association partnering with phaware on the Vancouver Interviews 2026 event. Directly comparable in advocacy mission and PH community engagement, primarily serving Canadian patients while co-developing content with phaware.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PHAWARE GLOBAL ASSOCIATION

Rare Disease Advocacy and Patient Educationphaware.global

Phaware global association is a 501(c)(3) nonprofit that builds digital tools, media, and educational programs — including the Heart Works mobile research app and a 600+ episode podcast — to advance pulmonary hypertension awareness, research participation, and clinician education globally across 110+ countries.

What PHAWARE GLOBAL ASSOCIATION does

phaware global association is a 501(c)(3) nonprofit founded in 2015 and headquartered in Burbank, California, that develops digital tools, media, and educational programs for the global pulmonary hypertension (PH) community. Its core assets are the Heart Works mobile research application (iOS, Android, Apple Watch, Amazon) — which enables remote six-minute walk testing, wearable-derived actigraphy/heart rate/oxygen saturation capture, and clinical trial matching via Antidote Match — and the 'I'm Aware That I'm Rare' podcast, which has produced over 600 episodes distributed to listeners in 110+ countries. Supplementary content includes the 'Aware I'm Rare' short film, the 'Lips Painted Blue' pediatric animated series, and free CME/CE modules on PAH for healthcare professionals delivered via a partnership with Prime Education.

The platform architecture is built around two technical differentiators: a validated remote 6MWT — under study with Stanford (DynAMITE PAH Study) and the University of Alberta (CRAVE pilot) — that aims to qualify home-based exercise testing for PH clinical trials, and an AI-powered Patient Lived Experience Portal that answers patient questions across 20+ languages using the organization's content library, with audio delivery supported by ElevenLabs through its Impact Program.

The business model is nonprofit and donation- and sponsorship-funded rather than transaction-based. Patient-facing products (app, podcast, films) are free; the only retail product line is branded merchandise sold at a flat $10 unit price (pins, ceramic pendants, PopSockets, earphones) with net proceeds directed to PH research funds. Operating cash flow depends on individual donations (including DAF Direct), grants, and corporate sponsorships from a 2026 roster of six pharmaceutical companies — Merck, Johnson & Johnson, Liquidia Technologies, Gossamer Bio, Pulmovant, and Insmed — plus on-site advertising (e.g., Yutrepia) on phaware.global. Custom primary customers are PH/PAH patients and caregivers, healthcare professionals (pulmonologists, cardiologists, NPs, PAs, pharmacists), and academic clinical researchers; the organization has 1–10 employees.

PHAWARE GLOBAL ASSOCIATION firmographics

Firmographics
Name
PHAWARE GLOBAL ASSOCIATION
Legal name
phaware global association
Website
https://phaware.global
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
Phaware global association is a 501(c)(3) nonprofit that builds digital tools, media, and educational programs — including the Heart Works mobile research app and a 600+ episode podcast — to advance pulmonary hypertension awareness, research participation, and clinician education globally across 110+ countries.
Ownership category
akta.pro rank

PHAWARE GLOBAL ASSOCIATION industry classification

Industry
Product category
Rare Disease Advocacy and Patient Education
NAICS
Other Similar Organizations (except Business, Professional, Labor, and Political Organizations) (813990), Motion Picture and Video Industries (5121), Scientific Research and Development Services (5417)
SIC
Services-Misc Health & Allied Services, Nec (8090), Miscellaneous Publishing (2741)
akta.pro industry
PRIMARYHLACAOAB
eCOA/ePRO/eDiary & Patient-Facing Data Collection
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYEDAGALAM
Audio Learning Content (Podcasts, Audiobooks, Listening Programs)
Education/Educational Publishing & Learning Content/Educational Media & Multimedia (Video, Audio, Interactive)

Keywords

  • Pulmonary hypertension awareness
  • Rare disease advocacy
  • Patient education resources
  • Mobile health research
  • Medical professional training

Where PHAWARE GLOBAL ASSOCIATION is headquartered

Location

Headquarters

HQ city
Burbank
HQ country
United States
HQ region
North America

Offices1 record

Markets served

PHAWARE GLOBAL ASSOCIATION business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

  1. Donations and Charitable Contributions: As a 501(c)(3) nonprofit organization, phaware receives tax-deductible donations from individuals and organizations. The organization promotes donor-advised fund (DAF) giving through DAF Direct.
  2. Corporate Sponsorship: Annual sponsorship support from pharmaceutical companies including Merck, Johnson & Johnson, Liquidia Technologies, Gossamer Bio, Pulmovant, and Insmed. These sponsorships support webinars, events, and general operations.
  3. Merchandise Sales: Online store selling branded merchandise (pins, pendants, PopSockets, earphones) at $10 per item. All net proceeds go directly to PH research funds.
  4. Pharmaceutical Advertising: The platform hosts sponsored content from pharmaceutical companies including Yutrepia (Liquidia Technologies) advertisements on the website.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goBranded merchandise (pins, pendants, PopSockets, earphones) - $10 per item
FreemiumPay-as-you-goHeart Works mobile app - Free
FreemiumPay-as-you-goCME/CE educational content - Free

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

PHAWARE GLOBAL ASSOCIATION product offering

Product offering

Core offering

phaware global association is a 501(c)(3) nonprofit that develops digital tools, media, and educational resources to advance pulmonary hypertension awareness and research. Its core offerings include the Heart Works mobile research app (remote six-minute walk testing, wearable data collection, clinical trial matching, and AI-powered patient education), the 'I'm Aware That I'm Rare' podcast series with 600+ episodes, CME/CE accredited medical education, branded awareness merchandise, and short film/animated content, all distributed globally to patients, caregivers, clinicians, and researchers.

Product overview

PHAWARE GLOBAL ASSOCIATION operates a unified digital health platform centered on the Heart Works mobile research application, complemented by the I'm Aware That I'm Rare podcast series (600+ episodes), educational films, animated content for children, and CME/CE programs for healthcare professionals. The organization also sells branded merchandise (trading pins, earphones, ceramic pendants, PopSockets) through its store, with all net proceeds directed to pulmonary hypertension research funds. The Heart Works app serves as the primary product, integrating wearable device data collection, clinical trial matching, and AI-powered patient education across 40+ countries.

Differentiator

Problem solved

Functional benefit

Brands

  • Heart Works: A pulmonary hypertension mobile research and resource app that enables real-time health tracking, at-home six-minute walk tests, remote clinical trial participation, and connects patients with the global PH community.
  • I'm Aware That I'm Rare Podcast
  • Aware I'm Rare Film

Products and services

  • Heart Works App A free pulmonary hypertension mobile research application for iOS and Android that enables remote patient monitoring, at-home six-minute walk testing with Apple Watch and Android wearables, clinical trial matching via Antidote Match, AI-powered patient education in 20+ languages through the Patient Lived Experience Portal, and access to the global PH community. Available in 40+ countries for PH patients.
  • I'm Aware That I'm Rare Podcast A weekly podcast series devoted to raising global pulmonary hypertension awareness featuring dynamic stories from PH patients, caregivers, and medical professionals from around the world, with over 600 episodes distributed via standard podcast players and dedicated iPhone, Android, and Amazon apps. Heard in 110+ countries.
  • Aware I'm Rare Film

Quantifiable outcome

  • 600+ podcast episodes produced and distributed globally
  • +3 more outcomes

Companies that use PHAWARE GLOBAL ASSOCIATION

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles5 records

PHAWARE GLOBAL ASSOCIATION technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability4 records

Feature4 records

PHAWARE GLOBAL ASSOCIATION partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Stanford MedicinecoreStrategic or Co-development PartnerAcademic partner conducting the DynAMITE PAH Study for self-administered 6MWT validation. Dr. Roham Zamanian (Stanford) serves as principal investigator and medical advisor/board member to phaware.
  • University of AlbertacoreStrategic or Co-development PartnerAcademic research partner for the CRAVE pilot study testing novel therapies for right heart failure in pulmonary hypertension patients. Dr. Jason Weatherald serves as principal investigator.
  • PHAEuropecoreOthersEuropean pulmonary hypertension association collaborating with phaware to advance global PH awareness and provide resources for European patients.
  • PHA CanadacoreOthersCanadian PH association partnering with phaware for the Vancouver Interviews 2026 event at their PH Community Conference in Vancouver, Canada.
  • PPHNetcoreOthersPulmonary hypertension network organization collaborating as a core partner in the Heart Works ecosystem to connect patients with PH resources globally.
  • Team PHenomenal HopeminorOthersPatient advocacy organization partnering with phaware to support the global PH community through awareness initiatives.
  • Pulmonary Hypertension NewsminorOthersBionews-owned publication providing PH news content and updates within the Heart Works app platform for patient education.
  • Prime EducationcoreStrategic or Co-development PartnerHealthcare education company providing free accredited CME/CE activities for healthcare professionals on PAH topics including diagnosis, treatment guidelines, and management strategies.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

PHAWARE GLOBAL ASSOCIATION competitors and assessment

Company assessment

Broad incumbents

  • Pulmonary Hypertension Association (PHA): The leading US-based pulmonary hypertension patient advocacy nonprofit with the largest membership base and longest operating history. PHA is the closest comparable in mission (PH awareness, education, research support) but operates at materially larger scale and offers broader patient services beyond phaware's digital-content focus.
  • National Organization for Rare Disorders (NORD): US umbrella organization for all rare diseases including PH. Comparable in nonprofit advocacy and patient-education mission, but operates at much larger scale across thousands of conditions rather than specializing in PH.

Others

  • Prime Education: Healthcare education company co-developing phaware's accredited CME/CE activities. Comparable as an enabling partner in HCP education rather than a competing advocacy organization, but useful as a benchmark for monetizing PH education content at scale.
  • Antidote (Antidote Match): Clinical trial matching technology provider integrated into phaware's Heart Works app. Comparable as an enabling technology for patient-recruitment workflows, though operating as a vendor/partner rather than a direct advocacy competitor.

Regional players

  • Scleroderma Foundation: US patient advocacy nonprofit for scleroderma, a related rare connective-tissue disease that frequently involves pulmonary hypertension. Comparable as a rare-disease advocacy nonprofit with overlapping patient population and similar pharmaceutical-sponsorship model.

Direct peers

  • PHA Europe: European umbrella pulmonary hypertension patient association and active phaware partner. Directly comparable in advocacy mission and PH-awareness content focus, serving the same patient population across Europe rather than competing for the same primary user base.
  • Team PHenomenal Hope: PH patient advocacy nonprofit focused on endurance fundraising and community engagement. Comparable in PH-specific advocacy mission with overlapping digital-community and awareness activities; both compete for similar donor mindshare.
  • PPHNet (Pulmonary Hypertension Network): Pediatric and adult pulmonary hypertension clinical research network and active phaware partner. Comparable in PH-specific mission but more clinically/research-oriented than patient-content-oriented, making it a complementary peer within the same disease niche.
  • PHA Canada: Canadian PH patient association partnering with phaware on the Vancouver Interviews 2026 event. Directly comparable in advocacy mission and PH community engagement, primarily serving Canadian patients while co-developing content with phaware.

Emerging players

  • Pulmonary Hypertension News (Bionews): Bionews-owned digital publication providing PH-specific news and patient education; a content partner that runs adjacent to phaware's podcast/app ecosystem. Comparable as a PH-information destination serving the same patient audience via different content format.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

PHAWARE GLOBAL ASSOCIATION social profiles

Digital presence

PHAWARE GLOBAL ASSOCIATION financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PHAWARE GLOBAL ASSOCIATION leadership team

Management profile

Number of profiles

Profiles7 records

PHAWARE GLOBAL ASSOCIATION funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PHAWARE GLOBAL ASSOCIATION M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PHAWARE GLOBAL ASSOCIATION

What does PHAWARE GLOBAL ASSOCIATION do?

phaware global association is a 501(c)(3) nonprofit that develops digital tools, media, and educational resources to advance pulmonary hypertension awareness and research. Its core offerings include the Heart Works mobile research app (remote six-minute walk testing, wearable data collection, clinical trial matching, and AI-powered patient education), the 'I'm Aware That I'm Rare' podcast series with 600+ episodes, CME/CE accredited medical education, branded awareness merchandise, and short film/animated content, all distributed globally to patients, caregivers, clinicians, and researchers.

Is PHAWARE GLOBAL ASSOCIATION a public or private company?

PHAWARE GLOBAL ASSOCIATION is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was PHAWARE GLOBAL ASSOCIATION founded?

PHAWARE GLOBAL ASSOCIATION was founded in 2015. It employs 1 to 10 people.

Where is PHAWARE GLOBAL ASSOCIATION based?

PHAWARE GLOBAL ASSOCIATION is headquartered in Burbank, United States, in the North America region.

How does PHAWARE GLOBAL ASSOCIATION make money?

Four revenue lines are on record. Donations and Charitable Contributions are the primary driver. The others are corporate Sponsorship, merchandise Sales and pharmaceutical Advertising.

Who are PHAWARE GLOBAL ASSOCIATION's main competitors?

Broad incumbents on record are Pulmonary Hypertension Association (PHA) and National Organization for Rare Disorders (NORD). Others are Prime Education and Antidote (Antidote Match). Scleroderma Foundation is listed as a regional player. Direct peers are PHA Europe, Team PHenomenal Hope, PPHNet (Pulmonary Hypertension Network) and PHA Canada. Pulmonary Hypertension News (Bionews) is listed as an emerging player.

Does PHAWARE GLOBAL ASSOCIATION have an API?

No public API is recorded for PHAWARE GLOBAL ASSOCIATION.

What industry is PHAWARE GLOBAL ASSOCIATION in?

PHAWARE GLOBAL ASSOCIATION's product category is Rare Disease Advocacy and Patient Education. Its primary akta.pro industry code is HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection, with a secondary code of HLACAOAM, Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms. Its NAICS code is 813990 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals